Davis, S. orcid.org/0000-0002-6609-4287, Goodacre, S., Horner, D. et al. (5 more authors) (2023) Decision-analysis modelling of effectiveness and cost-effectiveness of pharmacological thromboprophylaxis for surgical inpatients, using variable risk assessment models or other strategies. Journal of Thrombosis and Haemostasis, 21 (6). pp. 1580-1591. ISSN 1538-7836
Abstract
Background
Surgical inpatients are at risk of venous thromboembolism (VTE) which can be life-threatening or result in chronic complications. Thromboprophylaxis reduces VTE risk but incurs costs and may increase bleeding risk. Risk assessment models (RAMs) are currently used to target thromboprophylaxis at high-risk patients.
Objective
To determine the balance of cost, risk, and benefit for different thromboprophylaxis strategies in adult surgical inpatients, excluding major orthopaedic surgery, critical care and pregnant women.
Methods
Decision analytic modelling to estimate the following outcomes for alternative thromboprophylaxis strategies: thromboprophylaxis usage; VTE incidence and treatment; major bleeding; chronic thromboembolic complications; and overall survival. Strategies compared were: no thromboprophylaxis; thromboprophylaxis for all; and thromboprophylaxis given according to RAMs (Caprini and Pannucci). Thromboprophylaxis is assumed to be given for the duration of hospitalisation. The model evaluates life-time costs and quality-adjusted life-years (QALYs) within England’s health and social care services.
Results
Thromboprophylaxis for all surgical inpatients had a 70% probability of being the most cost-effective strategy (at a £20,000 per QALY threshold). RAM-based prophylaxis would be the most cost-effective strategy if a RAM with higher sensitivity (99.9%) were available for surgical inpatients. QALY gains were mainly due to reduced post-thrombotic complications. The optimal strategy was sensitive to several other factors including: risk of VTE, bleeding and post thrombotic syndrome; duration of prophylaxis and patient age.
Conclusions
Thromboprophylaxis for all eligible surgical inpatients appeared to be the most cost-effective strategy. Default recommendations for pharmacological thromboprophylaxis, with the potential to ‘opt-out’, may be superior to a complex risk-based ‘opt-in’ approach.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Keywords: | Anticoagulants; cost-benefit analysis; surgical procedures, operative; risk assessment; venous thromboembolism |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research |
Funding Information: | Funder Grant number DEPARTMENT OF HEALTH AND SOCIAL CARE NIHR127454 |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 06 Mar 2023 13:40 |
Last Modified: | 01 Oct 2024 14:05 |
Status: | Published |
Publisher: | Elsevier |
Refereed: | Yes |
Identification Number: | 10.1016/j.jtha.2023.02.018 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:196747 |
Downloads
Filename: 1-s2.0-S1538783623001666-main.pdf
Licence: CC-BY 4.0
Filename: VTEAM_paper_surg_JTH5_suppl_rev.pdf
Licence: CC-BY 4.0